Definitive Contract 75N93020C00034
- Not listed
- This is a $299,633 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "smartphone-integrated point-of-care sensor for rapid and sensitive detection of malaria in low-resource applications." Giner Inc. has experience delivering technology...
- This is a $299,966.00 firm fixed-price SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Giner Inc., a small business research and development firm based in Boston. The contract is for the development of point-of-care monitoring technologies to assess adherence to antiretroviral HIV therapy. The original contract opportunity was part of a broader SBIR solicitation from the National Institutes of Health (NIH) and Centers for Disease Control...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Giner Inc., a small business research and development firm based in Auburndale, Massachusetts. The $1,099,888.52 fixed-price contract is for a project titled "Rapid and Reprogrammable Assay for Multiplexed Gene Detection," which involves research support services. The contract is set aside for total small business participation and has an ultimate completion date of...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,979.00 firm fixed-price definitive contract to Giner Inc., a small business, for the development of a rapid, point-of-care sensor for the detection of Hepatitis C virus infections. The contract has a completion date of May 31, 2023. Giner Inc. is a research and development firm based in Auburndale, Massachusetts that specializes in developing cutting-edge...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Mental Health (NIMH) to Giner Inc., a small business research and development firm based in Boston. The contract, valued at $306,499.12, is for the development of point-of-care HIV viral load and drug adherence assays. This aligns with NIMH's mission to advance research on mental health and HIV/AIDS. The contract was set aside for small businesses and is part of the broader DHHS SBIR/STTR...
- This contract is an SBIR Phase I award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Giner Inc., a Boston-based research and development firm. The contract, valued at $149,983.00, is for a Small Business Innovation Research (SBIR) project and does not have a set-aside designation. Giner Inc. is a for-profit, subchapter S corporation that specializes in developing cutting-edge electrochemical technologies, including those for clean energy,...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Giner Inc., a small business research and development firm based in Auburndale, Massachusetts. The $299,749 firm-fixed-price contract is for biomedical research and development work. Giner Inc. has a history of securing federal contracts and grants from agencies like NASA, the Department of Defense, and the Department of Energy to develop advanced...
- This is a $222,608 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Giner Inc., a Boston-based research and development firm. The contract is for the "Development of a pO2 Guided Core Needle Tumor Biopsy Device" under SBIR Topic 331. Giner Inc. is a for-profit, Subchapter S Corporation that has extensive experience delivering research, prototypes, and products to federal agencies like NASA, the Department of Defense, and the...
- This is a $149,988.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "Rapid Touch Alcohol Sensor System" from July 1, 2008 to December 31, 2008, with a final completion date of March 31, 2010. Giner Inc. is a small business that has received numerous federal contracts...
- This is a firm fixed-price STTR Phase I contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Giner Inc., a Boston-based research and development firm, for the project "RAPID AND REPROGRAMMABLE ASSAY FOR MULTIPLEXED GENE DETECTION". The contract, with a ceiling value of $166,430.81, was awarded on April 12, 2020 and has a completion date of February 11, 2022. The contract is set aside for small businesses. Giner Inc. is a Subchapter S Corporation that has extensive...
This Small Business Innovation Research Phase I contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc. for $299,949. The contract calls for the development of a low-cost and robust nucleic acid sensor instrument that can rapidly and accurately identify the presence of dimorphic fungal species to yield early and definitive diagnosis of endemic fungal diseases such as histoplasmosis and coccidioidomycosis. The contract responds to a solicitation seeking proposals for Phase I and Phase II SBIR contracts to conduct research and development in support of NIH and CDC agency missions, including technologies for cancer, opioids, and environmental health. With a period of performance of September 1, 2020 through August 31, 2021 and using a firm fixed price contract type, this total small business set-aside award will be performed by Giner Inc. at its place of performance in Auburndale, Massachusetts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $299.9k | 7/29/20 |